Susquehanna International Group
TARA icon

Susquehanna International Group’s Protara Therapeutics TARA Stock Holding History

Susquehanna International Group’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$151K Buy
29,000
+15,400
+113% +$91.1K ﹤0.01% 11992
2025
Q4 		$72.5K Buy
+13,600
New +$75.6K ﹤0.01% 11611
2025
Q3 		– Sell
-23,900
Closed -$72.4K – 13843
2025
Q2 		$72.4K Sell
23,900
-80,100
-77% -$276K ﹤0.01% 11966
2025
Q1 		$443K Sell
104,000
-3,800
-4% -$17K ﹤0.01% 9160
2024
Q4 		$569K Buy
+107,800
New +$348K ﹤0.01% 8353

Other funds holding TARA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Susquehanna International Group's TARA Position: Q1 2026 in Review

Susquehanna International Group increased its Protara Therapeutics (TARA) stake by 9.2% in Q1 2026, buying an estimated $57.9K and bringing the position to 116,626 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #9159.

Susquehanna International Group first reported a position in TARA in Q1 2017 and has held it in 21 quarters since. The position peaked at $1.17M in Q1 2025. 114 funds tracked by Wall St. Rank hold TARA as of Q1 2026.

  • Susquehanna International Group held 116,626 shares of Protara Therapeutics worth $608K as of Q1 2026.
  • Susquehanna International Group bought 9,780 Protara Therapeutics shares in Q1 2026, an estimated $57.9K.
  • Protara Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9159 holding.
  • Susquehanna International Group first reported a position in Protara Therapeutics in Q1 2017 and has held it in 21 quarters since.
  • Susquehanna International Group's Protara Therapeutics position peaked at $1.17M in Q1 2025.
  • 114 funds tracked by Wall St. Rank held Protara Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.